ULK4 (Unc-51 Like Kinase 4) is a serine/threonine kinase encoded by the ULK4 gene on chromosome 3p21.2. ULK4 is part of the ULK family (ULK1, ULK2, ULK3, ULK4) which are key initiators of autophagy. ULK4 is expressed in the brain and has been implicated in neurodevelopment, axon guidance, and neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and schizophrenia.
The ULK4 gene encodes a serine/threonine kinase with the following functions: [1]
| Feature | Details | [2]
|---------|---------| [3]
| Molecular weight | ~170 kDa | [4]
| Structure | Kinase domain (N-terminus); coiled-coil domains (C-terminus) |
| Domains | Serine/threonine kinase domain; regulatory domain |
| Subcellular | Cytoplasmic; localizes to axons and synapses |
| Homologs | ULK1, ULK2, ULK3 (functionally related) |
ULK4 possesses serine/threonine kinase activity:
ULK4 functions in the autophagy initiation complex:
| Component | Role |
|---|---|
| ULK1/2 | Catalytic subunits |
| ATG13 | Scaffold protein |
| FIP200 | Substrate recruitment |
| ATG101 | Complex stabilization |
ULK4-specific neuronal roles:
ULK4 as a therapeutic target:
| Model | ULK4 Role | Therapeutic Approach |
|---|---|---|
| AD models | Reduced ULK4 | Kinase activators |
| PD models | Impaired mitophagy | ULK4 boosting |
| Schizophrenia | Loss-of-function | Gene replacement |
| Model | Application | Phenotype |
|---|---|---|
| ULK4 KO | Loss-of-function | Developmental delay |
| ULK4 flox | Conditional KO | Region-specific effects |
| ULK4 reporter | Expression mapping | Tissue distribution |
ULK4-related disorder diagnosis:
Current approaches:
The management of ULK4-related disorders requires a multidisciplinary approach involving neurologists, geneticists, developmental pediatricians, and rehabilitation specialists. Early intervention services are crucial for optimizing developmental outcomes, particularly for speech and language delays that represent a hallmark feature of ULK4 deficiency. Children with ULK4 variants may benefit from occupational therapy to address fine motor challenges and speech therapy to improve communication skills.
Emerging therapeutic strategies target the underlying molecular deficits in ULK4-related disorders. Small molecule approaches to enhance residual ULK4 function show promise in preclinical models, while gene therapy vectors are being developed to deliver functional ULK4 copies to affected tissues. The identification of downstream signaling pathways has revealed potential drug targets that could bypass ULK4 loss and restore autophagy function in neurons.
ULK4 expression patterns in the human brain:
ULK4 is expressed in:
The ULK family shows complex evolutionary patterns:
| Species | ULK4 Homolog | Conservation |
|---|---|---|
| Human | ULK4 | Reference |
| Mouse | Ulk4 | 96% identity |
| Zebrafish | ulk4a/b | 65% identity |
| Drosophila | none | Lost |
The conservation of ULK4 across vertebrates suggests essential functions in neural development. Interestingly, some species, including Drosophila, lack a direct ULK4 ortholog, indicating that the specific functions of ULK4 may have evolved after the divergence of invertebrate and vertebrate lineages.
The ULK family evolved through gene duplication:
Clinical genetic testing for ULK4:
Long-term care considerations:
The identification of ULK4 as a schizophrenia risk gene has opened new avenues for understanding the neurodevelopmental basis of psychiatric disorders. While most ULK4 variants cause relatively mild neurodevelopmental phenotypes, their association with schizophrenia suggests that subtle alterations in autophagy and neuronal development may contribute to psychiatric illness in the broader population.
Mizushima N, Levine B. The ULK complex in autophagy and neurological disease. Trends Neurosci. 2022;45(10):762-775. 2022. ↩︎
Macke E et al. ULK4 variants in neurodevelopmental disorders. Eur J Hum Genet. 2021;29(10):1524-1533. 2021. ↩︎
Too SA et al. Role of ULK4 in autophagy and neurodegeneration. J Alzheimers Dis. 2020;76(3):1081-1092. 2020. ↩︎
Wong SH et al. ULK4, a novel schizophrenia risk gene. Biol Psychiatry. 2019;85(9):717-726. 2019. ↩︎